Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
12:24:13 EDT Thu 09 May 2024
Enter Symbol
or Name
USA
CA



V:RKV - Rakovina Therapeutics Inc. - http://www.rakovinatherapeutics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
RKV - V15.00.085·0.0910.00.085-0.005-5.62.0010.085  0.085  0.0850.16  0.00511:34:00May 0815 min RT 2¢

Recent Trades - All 1 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
11:34:00V0.085-0.0052,00098 Red Cloud1 AnonymousKL
        
        
        
        
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-05-08 13:23C:RKV0.09News ReleaseRakovina expands Deep Docking research partnerships
2024-04-26 22:16C:RKV0.09SEDAR MD & ASEDAR MD & A
2024-04-26 21:51C:RKV0.09SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-04-26 20:47C:RKV0.09News ReleaseRakovina Therapeutics ends 2023 with cash of $436,313
2024-04-19 19:33C:RKV0.09Shares for DebtRakovina Therapeutics 255,425 shares for debt
2024-04-09 16:18C:RKV0.09News ReleaseRakovina presents data on kt-3000 series at AACR
2024-04-01 10:16C:RKV0.10News ReleaseRakovina hires Insight Capital for advisory services
2024-03-27 16:23C:RKV0.095News ReleaseRakovina signs agreement for Deep Docking AI platform
2023-11-27 19:54C:RKV0.07News ReleaseRakovina has cash of $813,328 at Sept. 30
2023-11-27 19:07C:RKV0.07SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-27 19:04C:RKV0.07SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-27 12:59C:RKV0.07News ReleaseRakovina appoints Cherkasov as scientific adviser
2023-11-20 14:25C:RKV0.075News ReleaseRakovina appoints Hamerlik as scientific adviser
2023-08-29 17:44C:RKVSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-29 17:38C:RKVSEDAR Interim MD & ASEDAR Interim MD & A
2023-08-29 13:45C:RKV0.105News ReleaseRakovina spends $391,969 on R&D in Q2 2023
2023-06-29 00:01C:RKV0.135News ReleaseRakovina shareholders re-elect four directors at AGM
2023-06-14 18:33C:RKV0.135Private Placement - DebentureRakovina $1,514,000 debenture private placement
2023-05-31 14:03C:RKV0.13News ReleaseRakovina spends $433,344 on R&D in Q1 2023
2023-05-30 21:36C:RKV0.13SEDAR Interim Financial StatementsSEDAR Interim Financial Statements